🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Matteo Marchesini

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0001-9489-7899

Also affiliated with Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Istituti di Ricovero e Cura a Carattere Scientifico

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy”.

Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

Nature Medicine(2022)10.1038/s41591-022-01696-4

N/A

2.2DataRank · unranked

83 citations

Hui Yang, Feiyang Ma, Guillermo Montalban‐Bravo, Natthakan Thongon, Valentina Marchica +33 more

Hematopoiesis under telomere attrition at the single-cell resolution

Nature Communications(2021)10.1038/s41467-021-27206-7

N/A

0DataRank · unranked

36 citations

Feiyang Ma, Andrea Santoni, Matteo Marchesini, Elena Fiorini, Ashley Rose +20 more

Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia

Cell Death and Disease(2022)10.1038/s41419-022-05002-5

N/A

0DataRank · unranked

13 citations

Samuel Kitara, Elisa Cerretani, Matteo Marchesini, Chiara Rompietti, Luca Pagliaro +24 more

Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.22.529457

N/A

0DataRank · unranked

1 citations

Feiyang Ma, Pamela Lockyer, Natalia Baran, Jintan Liu, C. Ellen Jackson +27 more